Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Carcinoma of Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05888831
What this trial is testing

BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 100
Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Testing effectiveness (Phase 2)UnknownNCT03119519
What this trial is testing

Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Southern Medical University, China 148
Early research (Phase 1)UnknownNCT05580172
What this trial is testing

Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Safety Issues
ReHeva Biosciences,Inc. 6
Not applicableActive Not RecruitingNCT01888601
What this trial is testing

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)

Who this might be right for
Non-small Cell Lung Cancer
University College, London 814
Testing effectiveness (Phase 2)Study completedNCT03129256
What this trial is testing

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Changzhou Cancer Hospital of Soochow University 52
Testing effectiveness (Phase 2)Study completedNCT01048645
What this trial is testing

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Institute of Cancerología 107
Large-scale testing (Phase 3)Looking for participantsNCT06452277
What this trial is testing

Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Who this might be right for
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Bayer 555
Not applicableStudy completedNCT04667312
What this trial is testing

Observational Study of Durvalumab in Patients With Non-small-cell Lung Cancer in the United Kingdom

Who this might be right for
Non-Small Cell Lung Cancer NSCLC
AstraZeneca 115
Large-scale testing (Phase 3)Looking for participantsNCT07182682
What this trial is testing

Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery

Who this might be right for
Non-Small Cell Lung Cancer
Dizal (Jiangsu) Pharmaceutical Co., Ltd. 360
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Post-approval studies (Phase 4)Ended earlyNCT04381494
What this trial is testing

Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab.

Who this might be right for
Unresectable Stage III NSCLC
AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT01131429
What this trial is testing

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

Who this might be right for
Neoplasms, LungCarcinoma, Non-Small Cell LungDrug Therapy+1 more
Chinese PLA General Hospital 60
Testing effectiveness (Phase 2)Study completedNCT01004731
What this trial is testing

Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer

Who this might be right for
Stage IV Non-Small Cell Lung Cancer
University of Alabama at Birmingham 7
Testing effectiveness (Phase 2)WithdrawnNCT05481775
What this trial is testing

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Non-small Cell Lung CancerEfficacy and Safety
Sun Yat-sen University
Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04105153
What this trial is testing

Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC

Who this might be right for
EGFR Positive Non-small Cell Lung Cancer
Thoraxklinik-Heidelberg gGmbH 400
Not applicableEnrolling By InvitationNCT06752395
What this trial is testing

Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions

Who this might be right for
Lung Cancer (NSCLC)
Pusan National University Hospital 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05211895
What this trial is testing

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 791
Early research (Phase 1)Study completedNCT02858869
What this trial is testing

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaMucosal Melanoma+4 more
Emory University 25
Next Page